Dr. Brigitte Widemann, MD
Claim this profileNational Cancer Institute
Studies Nerve Sheath Tumors
Studies Neurofibrosarcoma
2 reported clinical trials
2 drugs studied
Area of expertise
1Nerve Sheath Tumors
Stage IV
PRC2 negative
2Neurofibrosarcoma
Stage IV
PRC2 negative
Affiliated Hospitals
Clinical Trials Brigitte Widemann, MD is currently running
ASTX727
for Peripheral Nerve Sheath Tumor
The purpose of this study is to see whether the study drug ASTX727 is an effective treatment for people who have MPNST with a PCR2 mutation. ASTX727 is a combination of two drugs (cedazuridine and decitabine) that have been designed to target cancer cells with a PCR2 mutation and to disrupt the cells' ability to survive and grow. The study researchers think that the study drug allows decitabine to work better than decitabine given alone.
Recruiting1 award Phase 213 criteria
Poly-ICLC
for Low-Grade Glioma
This trial is testing a medication called Poly-ICLC that boosts the immune system in children with NF1 who have brain tumors that don't respond to usual treatments. The goal is to see if this medication can help shrink or control the tumors by enhancing the body's natural defenses.
Recruiting1 award Phase 235 criteria
More about Brigitte Widemann, MD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Brigitte Widemann, MD has experience with
- ASTX727
- Poly ICLC
Breakdown of trials Brigitte Widemann, MD has run
Nerve Sheath Tumors
Neurofibrosarcoma
Peripheral Nerve Sheath Tumor
Neurofibromatosis
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brigitte Widemann, MD specialize in?
Brigitte Widemann, MD focuses on Nerve Sheath Tumors and Neurofibrosarcoma. In particular, much of their work with Nerve Sheath Tumors has involved Stage IV patients, or patients who are PRC2 negative.
Is Brigitte Widemann, MD currently recruiting for clinical trials?
Yes, Brigitte Widemann, MD is currently recruiting for 2 clinical trials in Bethesda Maryland. If you're interested in participating, you should apply.
Are there any treatments that Brigitte Widemann, MD has studied deeply?
Yes, Brigitte Widemann, MD has studied treatments such as ASTX727, Poly ICLC.
What is the best way to schedule an appointment with Brigitte Widemann, MD?
Apply for one of the trials that Brigitte Widemann, MD is conducting.
What is the office address of Brigitte Widemann, MD?
The office of Brigitte Widemann, MD is located at: National Cancer Institute, Bethesda, Maryland 20892 United States. This is the address for their practice at the National Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.